Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Covington
Queensland Health
Cantor Fitzgerald
Deloitte
Farmers Insurance
Colorcon
Novartis
Julphar
QuintilesIMS

Generated: October 22, 2017

DrugPatentWatch Database Preview

Etonogestrel - Generic Drug Details

« Back to Dashboard

What are the generic sources for etonogestrel and what is the scope of etonogestrel freedom to operate?

Etonogestrel
is the generic ingredient in two branded drugs marketed by Organon Usa Inc and is included in one NDA. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Etonogestrel has seventy-nine patent family members in thirty-one countries and four supplementary protection certificates in four countries.

There are four drug master file entries for etonogestrel. One supplier is listed for this compound.

Summary for Generic Name: etonogestrel

US Patents:3
Tradenames:2
Applicants:1
NDAs:1
Drug Master File Entries: see list4
Suppliers / Packagers: see list1
Bulk Api Vendors: see list20
Clinical Trials: see list43
Patent Applications: see list1,451
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:etonogestrel at DailyMed

Pharmacology for Ingredient: etonogestrel

Ingredient-typeProgesterone Congeners
Drug ClassProgestin
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Organon Usa Inc
NEXPLANON
etonogestrel
IMPLANT;IMPLANTATION021529-002May 31, 2011RXYesYes► Subscribe► SubscribeY ► Subscribe
Organon Usa Inc
NEXPLANON
etonogestrel
IMPLANT;IMPLANTATION021529-002May 31, 2011RXYesYes► Subscribe► SubscribeY ► Subscribe
Organon Usa Inc
IMPLANON
etonogestrel
IMPLANT;IMPLANTATION021529-001Jul 17, 2006DISCNNoNo► Subscribe► SubscribeY ► Subscribe
Organon Usa Inc
NEXPLANON
etonogestrel
IMPLANT;IMPLANTATION021529-002May 31, 2011RXYesYes► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: etonogestrel

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Organon Usa Inc
IMPLANON
etonogestrel
IMPLANT;IMPLANTATION021529-001Jul 17, 2006► Subscribe► Subscribe
Organon Usa Inc
IMPLANON
etonogestrel
IMPLANT;IMPLANTATION021529-001Jul 17, 2006► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: etonogestrel

Country Document Number Estimated Expiration
Portugal1729819► Subscribe
Norway20064716► Subscribe
Ukraine89518► Subscribe
Germany602005007873► Subscribe
European Patent Office1841492► Subscribe
South Korea101278854► Subscribe
Argentina055716► Subscribe
TaiwanI434676► Subscribe
BrazilPI0508865► Subscribe
Taiwan200640518► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: ETONOGESTREL

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
80027Netherlands► SubscribePRODUCT NAME: ETONOGESTREL; REGISTRATION NO/DATE: RVG 21168 19980825
9C0041Belgium► SubscribePRODUCT NAME: ETONOGESTREL; NATL. REGISTRATION NO/DATE: 52 IS 296 F 14 19990531; FIRST REGISTRATION: NL RVG 21168 19980825
C/GB99/044United Kingdom► SubscribePRODUCT NAME: ETONOGESTREL; REGISTERED: NL RGV21168 19980825; UK 00065/0161 19990609
/1999Austria► SubscribePRODUCT NAME: ETONOGESTREL; NAT. REGISTRATION NO/DATE: 1-22964 19990330; FIRST REGISTRATION: NL 21168 19980825
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Chinese Patent Office
US Department of Justice
AstraZeneca
Dow
Colorcon
Harvard Business School
US Army
McKesson
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot